Marex Group Limited Fundamental Analysis (NASDAQ: MRX)
Marex Group Limited Fundamental Analysis (NASDAQ: MRX)
Marex Group Limited (NASDAQ: MRX) shows moderate financial fundamentals with a PE ratio of 18.47, profit margin of 9.67%, and ROE of 31.85%. The company generates $4.9B in annual revenue with strong year-over-year growth of 25.39%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 46.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MRX's fundamental strength across five key dimensions:
Efficiency Score
WeakMRX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMRX trades at attractive valuation levels.
Growth Score
ExcellentMRX delivers strong and consistent growth momentum.
Financial Health Score
WeakMRX carries high financial risk with limited liquidity.
Profitability Score
WeakMRX struggles to sustain strong margins.
Key Financial Metrics
Is MRX Expensive or Cheap?
P/E Ratio
MRX trades at 18.47 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, MRX's PEG of 1.73 indicates fair valuation.
Price to Book
The market values Marex Group Limited at 2.93 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.69 times EBITDA. This is generally considered low.
How Well Does MRX Make Money?
Net Profit Margin
For every $100 in sales, Marex Group Limited keeps $9.67 as profit after all expenses.
Operating Margin
Core operations generate 43.75 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $31.85 in profit for every $100 of shareholder equity.
ROA
Marex Group Limited generates $1.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Marex Group Limited generates limited operating cash flow of $-247.44M, signaling weaker underlying cash strength.
Free Cash Flow
Marex Group Limited generates weak or negative free cash flow of $-251.53M, restricting financial flexibility.
FCF Per Share
Each share generates $-3.50 in free cash annually.
FCF Yield
MRX converts -5.03% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
18.47
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.73
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.93
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.01
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.51
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.32
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How MRX Stacks Against Its Sector Peers
| Metric | MRX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 18.47 | 21.10 | Better (Cheaper) |
| ROE | 31.85% | 652.00% | Weak |
| Net Margin | 9.67% | -1596.00% (disorted) | Weak |
| Debt/Equity | 1.51 | 0.91 | Weak (High Leverage) |
| Current Ratio | 0.00 | 910.69 | Weak Liquidity |
| ROA | 1.19% | 4471297.00% | Weak |
MRX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Marex Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
307.16%
Industry Style: Value, Dividend, Cyclical
High GrowthEPS CAGR
497.60%
Industry Style: Value, Dividend, Cyclical
High GrowthFCF CAGR
1338.99%
Industry Style: Value, Dividend, Cyclical
High Growth